Fortifying vaccines: Preparation and prevention against future infectious disease epidemics
Vaccines for COVID-19 were developed with unprecedented speed, beginning distribution less than one year after the emergence of the disease. These vaccines have played an integral role in controlling the pandemic, reducing hospitalisations and deaths, and easing the load on overburdened health systems. However, emerging infectious diseases are occurring with increasing frequency, meaning it is only a matter of time until the next health threat surfaces — and current standards of vaccine development are not sufficient to respond to rapidly spreading epidemic disease. Without conscious preparation, there is no guarantee that vaccine developers will be able to respond to future outbreaks with equal speed.
This whitepaper presents infrastructural and strategic considerations for strengthening vaccine development so that the medical community will be prepared to respond to future pandemics and novel diseases.
Download the whitepaper to discover:
- Why vaccines are critical to defend against future health threats
- Avenues of pre-emptive vaccine research that can enhance the ability to respond to future outbreaks of emerging infectious diseases
- The role of disease surveillance and smart data reporting in vaccine efficacy trials
- Strategies to improve the efficiency of vaccine clinical trials, including responsive trials, technology, and master protocols and adaptive trials